WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATC 5th levels

List of latest ATC/DDD decisions from the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the decisions should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline (see list). If no objections are received, the new ATC/DDD decisions will be considered final and included in the ATC/DDD Index. In the list final indicates that the date for objection has expired. The year of implementation in the ATC/DDD Index is given in the list.

Please note that the ATC and DDD alterations are only valid and implemented in the coming annual updates of January 1st.

ATC codeATC level nameDeadline for objection to temporary codesImplementation in ATC/DDD index
A02BC10fexuprazanFinal2025
A02BC11ilaprazoleFinal2025
A05AX07seladelpar01.09.20242025
A10BD30gemigliptin and dapagliflozinFinal2025
A10BK09enavogliflozinFinal2025
A10XX02donislecelFinal2025
A16AX24govorestatFinal2025
A16AX25nedosiran01.09.20242025
B02BD17fidanacogene elaparvovecFinal2025
B02BX11marstacimab01.09.20242025
B03XA09molidustatFinal2025
B03XA10efepoetin alfaFinal2025
B06AC07garadacimabFinal2025
B06AC08sebetralstat01.09.20242025
C01EB25acoramidisFinal2025
C02KX06sotaterceptFinal2025
C08DA03etripamilFinal2025
C09XX01sparsentanFinal2025
C10BA13pitavastatin and ezetimibeFinal2025
C10BX22rosuvastatin and nebivololFinal2025
J01DF51aztreonam and beta-lactamase inhibitorFinal2025
J01RA17ofloxacin and nitazoxanideFinal2025
J01RA18ofloxacin and tinidazoleFinal2025
J01RA19tetracycline and nystatinFinal2025
J01XX13gepotidacinFinal2025
J04AC02ftivazideFinal2025
J04AM09pyrazinamide, ethambutol, isoniazid and lomefloxacinFinal2025
J04AM10pyrazinamide, ethambutol, protionamide and lomefloxacinFinal2025
J04AM11rifabutin, pyrazinamide and protionamideFinal2025
J04AM12rifampicin, pyrazinamide, isoniazid and levofloxacinFinal2025
J05AG07elsulfavirineFinal2025
J05AP14narlaprevirFinal2025
J05AR29emtricitabine, tenofovir alafenamide and dolutegravirFinal2025
J05AX32riamilovirFinal2025
J05AX33labuvirtide01.09.20242025
J06BD09sipavibartFinal2025
J07AH11meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding proteinFinal2025
J07BB05influenza, RNA-based vaccineFinal2025
L01DC05utideloneFinal2025
L01EE05mirdametinib01.09.20242025
L01EL06tirabrutinibFinal2025
L01EX28repotrectinibFinal2025
L01FD07zanidatamabFinal2025
L01FX31zolbetuximabFinal2025
L01FX32elranatamabFinal2025
L01FX33tarlatamabFinal2025
L01FX34odronextamabFinal2025
L01FX35datopotamab deruxtecan01.09.20242025
L01FX36patritumab deruxtecan01.09.20242025
L01XH06tucidinostatFinal2025
L01XH07resminostatFinal2025
L01XL12obecabtagene autoleucel01.09.20242025
L01XM03olutasidenib Final2025
L01XM04vorasidenib Final2025
L01XX81nirogacestatFinal2025
L01XX82darinaparsin01.09.20242025
L01XX83para-toluenesulfonamide 01.09.20242025
L01XX84pelabresib01.09.20242025
L01XX85idroxioleic acid01.09.20242025
L01XX86calaspargase pegol01.09.20242025
L01XY04bifikafusp alfa and onfekafusp alfa01.09.20242025
L03AX23motixafortide01.09.20242025
L03AX24mavorixafor01.09.20242025
L04AA60remibrutinibFinal2025
L04AC26goflikiceptFinal2025
L04AG17seniprutugFinal2025
L04AJ10vilobelimabFinal2025
L04AJ11pozelimab01.09.20242025
L04AX10tegomil fumarate01.09.20242025
M01AE19loxoprofenFinal2025
M01AE20pelubiprofen01.09.20242025
N02CD08zavegepantFinal2025
N06AX31zuranoloneFinal2025
N07BB06ondelopranFinal2025
N07XX24trofinetideFinal2025
N07XX25omaveloxolone01.09.20242025
P01AB08satranidazoleFinal2025
P01AB53tinidazole and diloxanideFinal2025
R07AX33deutivacaftor, tezacaftor and vanzacaftor01.09.20242025
S01AX25lotilanerFinal2025
S01EA55brimonidine and ripasudilFinal2025
S01EE52latanoprost and dorzolamideFinal2025
S01XA32avacincaptad pegolFinal2025
S01XA33diquafosol01.09.20242025
V04CX12xenonFinal2025
V09IX18flotufolastat (18F)Final2025
V10XA04iodine (131I) apamistamabFinal2025

Last updated: 2024-05-07